Report Overview

The global sleep aids market size stood at around USD 63.11 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Sleep aids are mainly to help people who are suffering from sleeping disorders. These are the medications or herbs which allow a person to get rest. Sleep aids will block some brain chemicals, making a person sleep, while some medicines will later change the bodys natural circadian rhythms. As sleep is the most common thing for health factors and enables many organs to function healthy, the use of sleep aids will tend to reduce long term health disorders. Herbs and natural compounds included in natural remedies also play a crucial role in maintaining a healthy sleep cycle for a person.



Market Drivers

Changes in lifestyles and a rise in the number of people with no rest in day-to-day life are a major driving factor for the market to grow. Shifting trends to maintain a healthy lifestyle by maintaining a good sleep cycle is lavishing this market's demand to the extent. The increasing geriatric population also propels the sleep aids market. Nowadays, people are experiencing many health disorders due to lack of proper sleep, which may be due to hectic works, stress, and others, which is also an attribute accelerating the demand of the global sleep aids market.

Market Restraints

However, fluctuations in raw materials' availability, mostly natural products, are slowly degrading the market demand. The rise in the number of patients with side effects due to long term use of these medications has remained challenging for the market. Besides, lack of complete knowledge over the dosage forms while manufacturing the products in undeveloped countries inhibits the demand of the sleep aids market. Stringent rules and regulations by the government on pharmaceutical companies may also impact negatively on the growth rate of the sleep aids market.

Major Sleep Disorders

The major sleep disorders include insomnia, sleep apnea, restless legs syndrome, narcolepsy and sleep walking.

Based on sleep disorder, the insomnia segment accounts for a significant share globally in the sleep aids market during the forecast period. 10 % to 30% of adults and up to 50% to 60% suffer from insomnia annually, according to a study published by the International Journal of Contemporary Medical Research (IJCMR). The incidence of insomnia in people is increasing majorly due to work stress, depression, anxiety disorders, excessive smoking, and alcohol consumption.

The sleep apnea segment remains the fastest-growing segment than other sleep disorders due to the growing aging population, who are more vulnerable to sleep apnea disorders, growing developments in the manufacturing processes, and existing market economies.

The sleepwalking and restless Legs Syndrome segment are forecasted to have prominent growth during the forecast period. Increasing sleepwalking and restless syndrome cases have covered the way for the inflow of voluminous growth in the sleep aids market globally.